p53-dependent anticancer effects of leptomycin B on lung adenocarcinoma
✍ Scribed by Changxia Shao; Chuanwen Lu; Lixia Chen; Patrick P. Koty; Everardo Cobos; Weimin Gao
- Book ID
- 105993552
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 603 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. This study examined the prognostic information regarding the risk of postoperative tumor recurrence obtained by simultaneous determination of preoperative serum carcinoembryonic antigen (CEA) and immunohistochemical expression of p53 protein in tumor tissue from patients with colorec
## Abstract __In vitro__ studies suggest that __p__53 codon 72 genotype alters the apoptotic capacity of p53 protein, with the 72 arginine (R) form of wild‐type p53 harboring a greater apoptosis‐inducing potential than the 72 proline (P) variant. The aim of this study was to investigate whether the
## Abstract Inhibitors of cyclin‐dependent kinases (CDKs) undergoing clinical trials as anticancer agents usually target several CDKs in cells. Some of them are also able to increase cellular levels of p53 protein and to activate p53‐regulated transcription. To define the role of p53 in the antican